Dysthymia – ein umstrittenes Konzept

Die Dysthymia wurde erstmals in den späten 1970er-Jahren in DSM-III als milde, chronisch verlaufende Depressionsform eingeführt, um den Begriff der „depressiven Persönlichkeit“ zu ersetzen. Das Konzept war von Anfang an Gegenstand heftiger Kontroversen und ist bis heute umstritten. Dieser Beitrag zeigt, welchen Herausforderungen Kliniker*innen bei der Diagnose und Therapie der dysthymen Störung gegenüberstehen.

Schlüsselwörter

Klassifikation - Diagnostik - Leitlinien - Störungsorientierte Psychotherapie - CBASP - Dysthymia - Depression

Publication History

Article published online:
05 November 2021

• Literatur

• 1 Klein DN, Shankman SA, Rose S. Ten-year prospective follow-up study of the naturalistic course of dysthymic disorder and double depression. Am J Psychiatry 2006; 163: 872-880
• 2 Hellerstein D, Agosti V, Bos M. et al. Impairment in psychosocial functioning associated with dysthymic disorder in the NESARC Study. J Affect Disord 2010; 127: 84-88
• 3 Schramm E, Klein DN, Elsaesser M. et al. Review of dysthymia and persistent depressive disorder: history, correlates, and clinical implications. The Lancet Psychiatry 2020; 7: 801-812
• 4 Klein DN. Classification of depressive disorders in the DSM-V: Proposal for a two-dimension system. J Abnormal Psychol 2008; 117: 552-560
• 5 Cuijpers P, van Straten A, Schuurmans J. et al. Psychotherapy for chronic major depression and dysthymia: A meta-analysis. Clin Psychol Rev 2010; 30: 51-62
• 6 Nelson J, Klumparendt A, Doebler P. et al. Childhood maltreatment and characteristics of adult depression: Meta-analysis. Br J Psychiatry 2017; 210: 96-104
• 7 Nemeroff CB, Heim CM, Thase ME. et al. Differential responses to psychotherapy versus pharmacotherapy in patients with chronic forms of major depression and childhood trauma. Proc Natl Acad Sci 2003; 100: 14293-14296
• 8 Constantino MJ, Manber R, DeGeorge J. et al. Interpersonal styles of chronically depressed outpatients: profiles and therapeutic change. Psychotherapy (Chic) 2008; 45: 491-506
• 9 MacQueen G, Santaguida P, Keshavarz H. et al. Systematic review of clinical practice guidelines for failed antidepressant treatment response in major depressive disorder, dysthymia, and subthreshold depression in adults. Can J Psychiatry 2017; 62: 11-23
• 10 Bauer M, Adli M. Pharmakotherapie von chronischen und therapieresistenten depressiven Störungen. In: Voderholzer U, Hohagen F. Therapie psychischer Erkrankungen. State of the art. 16. Aufl.. München: Elsevier/Urban & Fischer; 2020
• 11 Browne G, Steiner M, Roberts J. et al. Sertraline and/or interpersonal psychotherapy for patients with dysthymic disorder in primary care: 6-month comparison with longitudinal 2-year follow-up of effectiveness and costs. J Affect Disord 2002; 68: 317-330
• 12 Markowitz JC, Kocsis JH, Bleiberg KL. et al. A comparative trial of psychotherapy and pharmacotherapy for “pure” dysthymic patients. J Affect Disord 2005; 89: 167-175
• 13 Ravindran AV, Anisman H, Merali Z. et al. Treatment of primary dysthymia with group cognitive therapy and pharmacotherapy: Clinical symptoms and functional impairments. Am J Psychiatry 1999; 156: 1608-1617
• 14 Hellerstein DJ, Yanowitch P, Rosenthal J. et al. A randomized double-blind study of fluoxetine versus placebo in the treatment of dysthymia. Am J Psychiatry 1993; 150: 1169-1175
• 15 Kriston L, von Wolff A, Westphal A. et al. Efficacy and acceptability of acute treatments for persistent depressive disorder: a network meta-analysis. Depress Anxiety 2014; 31: 621-630
• 16 Furukawa TA, Efthimiou O, Weitz ES. et al. Cognitive-Behavioral Analysis System of Psychotherapy, Drug, or Their Combination for Persistent Depressive Disorder: Personalizing the Treatment Choice Using Individual Participant Data Network Metaregression. Psychother Psychosom 2018; 87: 140-153
• 17 Kocsis JH, Leon AC, Markowitz JC. et al. Patient preference as a moderator of outcome for chronic forms of major depressive disorder treated with nefazodone, cognitive behavioral analysis system of psychotherapy, or their combination. J Clin Psychiatry 2009; 70: 354-361
• 18 von Wolff A, Hölzel LP, Westphal A. et al. Combination of pharmacotherapy and psychotherapy in the treatment of chronic depression: A systematic review and meta-analysis. BMC Psychiatry 2012; 12: 61
• 19 Keller MB, McCullough JP, Klein DN. et al. A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression. N Engl J Med 2000; 342: 1462-1470
• 20 Schramm E, Kriston L, Zobel I. et al. Effect of disorder-specific vs nonspecific psychotherapy for chronic depression: A randomized clinical trial. JAMA Psychiatry 2017; 74: 233-242
• 21 Leuzinger-Bohleber M, Hautzinger M, Fiedler G. et al. Outcome of psychoanalytic and cognitive-behavioural long-term therapy with chronically depressed patients: a controlled trial with preferential and randomized allocation. Can J Psychiatry 2019; 64: 47-58
• 22 Schramm E, Kriston L, Elsaesser M. et al. Two-year follow-up after treatment with the Cognitive Behavioral Analysis System of Psychotherapy versus supportive psychotherapy for early-onset chronic depression. Psychoth Psychosom 2019; 88: 154-164
• 23 Jobst A, Brakemeier E-L, Buchheim A. et al. European Psychiatric Association Guidance on psychotherapy in chronic depression across Europe. Eur Psychiatry 2016; 33: 18-36
• 24 McCullough JP. Treatment for chronic depression. Cognitive behavioral analysis system of psychotherapy. New York NY: Guilford Press; 2000.
• 25 Constantino MJ, Laws HB, Coyne AE. et al. Change in patients’ interpersonal impacts as a mediator of the alliance-outcome association in treatment for chronic depression. J Consult Clin Psychol 2016; 84: 1135-1344
• 26 Bohus M, Herpertz SC, Falkai P. Modulare Psychotherapie – Rationale und Grundprinzipien. Die Psychiatrie 2012; 9: 89-97